Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database
Arthritis & Rheumatology · 11.11.2026
DOI: 10.1002/art.70388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 11.11.2026. Verfasst von Akira Yoshida und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
Abstract (Originalsprache)
Objective
To better characterize the clinical phenotypes and heterogeneity of anti‐synthetase syndrome (ASyS), we performed unsupervised cluster analyses using clinical and serological data from the Classification Criteria for Anti‐Synthetase Syndrome (CLASS) project database.
Methods
The CLASS database comprised 2,035 ASyS cases and 2,140 comparators with mimicking conditions, namely systemic autoimmune rheumatic diseases and/or interstitial lung disease (ILD), contributed by 103 centers worldwide. We applied multiple correspondence analysis followed by hierarchical clustering using 19 clinical and serological variables to classify ASyS and comparators in the entire CLASS cohort into distinct subgroups. We then repeated the cluster analysis in the ASyS cohort alone to identify phenotypic subgroups of ASyS.
Results
Cluster analysis of the entire cohort identified three subgroups. Whereas Cluster 1 (n = 1,311) and Cluster 3 (n = 1,468) predominantly comprised ASyS and comparators, respectively, Cluster 2 (n = 1,105) included both groups. Interstitial pneumonia with autoimmune features (without anti‐synthetase autoantibodies) and systemic sclerosis were more prevalent in Cluster 2, whereas dermatomyositis and polymyositis were predominantly represented in Cluster 3. Cluster analysis of the ASyS cohort identified three distinct subgroups: Cluster 1 (anti‐Jo‐1‐positive, “full‐spectrum” ASyS with myositis, ILD, and arthritis; n = 1,034), Cluster 2 (ILD‐predominant; n = 581), and Cluster 3 (without ILD; n = 248).
Conclusion
Cluster analyses identified ASyS as a distinct and heterogeneous clinical entity. Three distinct phenotypic clusters emerged among patients with ASyS, with ILD‐predominant cases representing the second largest subgroup, underscoring the need for classification criteria that adequately capture patients presenting with isolated ILD. image
Autor:innen und Institutionen
- Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
- Section of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL, USA.
- Rheumatology Department, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal.
- Aveiro Rheumatology Research Centre, Egas Moniz Health Alliance, Aveiro, Portugal.
- Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
- Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy.
ORCID-Profile: Akira Yoshida, Eduardo Dourado, Gianluca Sambataro, Sangmee Sharon Bae, Andrew L Mammen, Chester V Oddis, David F Fiorentino, Frederick W Miller, Ingrid E Lundberg, Masataka Kuwana, Miguel Angel González-Gay, Maria Giovanna Danieli, Antonella Notarnicola, Rohit Aggarwal
Zitieren
APA
Yoshida, A., Ventura, I. B., Dourado, E., Zanframundo, G., Faghihi-Kashani, S., Loganathan, A., Gallegos, D. R., Bozan, F., Sambataro, G., Bae, S. S., Gallay, L., Selva-O'Callaghan, A., Mammen, A. L., Montecucco, C., Oddis, C. V., Fiorentino, D. F., Bonella, F., Miller, F. W., Lundberg, I. E., …, & Aggarwal, R. (2026). Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database. Arthritis & Rheumatology. https://doi.org/10.1002/art.70388
Vancouver
Yoshida A, Ventura IB, Dourado E, Zanframundo G, Faghihi-Kashani S, Loganathan A, et al. Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database. Arthritis & Rheumatology. 2026. doi:10.1002/art.70388
BibTeX
@article{Yoshida2026,
author = {Yoshida, Akira and Ventura, Iazsmin Bauer and Dourado, Eduardo and Zanframundo, Giovanni and Faghihi-Kashani, Sara and Loganathan, Aravinthan and Gallegos, Daphne Rivero and Bozan, Francisca and Sambataro, Gianluca and Bae, Sangmee Sharon and Gallay, Laure and Selva-O'Callaghan, Albert and Mammen, Andrew L and Montecucco, Carlomaurizio and Oddis, Chester V and Fiorentino, David F and Bonella, Francesco and Miller, Frederick W and Lundberg, Ingrid E and Rojas-Serrano, Jorge and Kuwana, Masataka and González-Gay, Miguel Angel and McHugh, Neil and Corte, Tamera J and Doyle, Tracy Jennifer and Jovani, Vega and Carli, Linda and Sainaghi, Pier Paolo and Umezawa, Natsuka and Needham, Merrilee and Cagnotto, Giovanni and Perez-Gómez, Nair and Tomietto, Paola and Limonta, Massimiliano and Danieli, Maria Giovanna and Notarnicola, Antonella and Cifrian-Martinez, José and Martinez-Barrio, Julia and Andersson, Helena and Kondoh, Yasuhiro and Voll, Reinhard Edmund and Tomaras, Stylianos and Basharat, Pari and Tamirou, Farah and Parronchi, Paola and Schneider, Matthias and CLASS project participating investigators, CLASS project participating investigators and Cavagna, Lorenzo and Aggarwal, Rohit},
title = {Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70388}
}
EUVIMED